{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:50:34Z","timestamp":1783003834662,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.eprac.2022.01.013","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T21:51:36Z","timestamp":1643925096000},"page":"391-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Can Active Surveillance Management be Developed for Patients With Low-Risk Papillary Thyroid Microcarcinoma? A Preliminary Investigation in a Chinese Population"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-2161","authenticated-orcid":false,"given":"Wen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-4780","authenticated-orcid":false,"given":"Ruochuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2022.01.013_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10.1016\/j.eprac.2022.01.013_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMp1409841","article-title":"Korea\u2019s thyroid-cancer \u201cepidemic\u201d\u2014screening and overdiagnosis","volume":"371","author":"Ahn","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.eprac.2022.01.013_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eprac.2022.01.013_bib4","doi-asserted-by":"crossref","first-page":"g7773","DOI":"10.1136\/bmj.g7773","article-title":"Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods","volume":"350","author":"Carter","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.eprac.2022.01.013_bib5","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/SLA.0000000000003580","article-title":"The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults","volume":"271","author":"Patel","year":"2020","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.eprac.2022.01.013_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072503321669875","article-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","volume":"13","author":"Ito","year":"2003","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1507\/endocrj.46.209","article-title":"Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors","volume":"46","author":"Sugitani","year":"1999","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2022.01.013_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3803\/EnM.2016.31.3.373","article-title":"The revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers: differences from the 2015 American Thyroid Association guidelines","volume":"31","author":"Yi","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.013_bib10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.013_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2022.01.013_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40618-018-0884-2","article-title":"Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies","volume":"41","author":"Pacini","year":"2018","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2022.01.013_bib13","doi-asserted-by":"crossref","first-page":"15533","DOI":"10.1038\/ncomms15533","article-title":"The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing","volume":"8","author":"Ye","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.013_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12020-020-02441-y","article-title":"2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS","volume":"70","author":"Zhou","year":"2020","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.eprac.2022.01.013_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2022.01.013_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejca.2019.10.017","article-title":"BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma","volume":"124","author":"Kim","year":"2020","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.eprac.2022.01.013_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.eprac.2022.01.013_bib18","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1210\/clinem\/dgz113","article-title":"Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center","volume":"105","author":"Molinaro","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2022.01.013_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/a-1015-6684","article-title":"Active surveillance in adults with low-risk papillary thyroid microcarcinomas: a prospective study","volume":"51","author":"Rosario","year":"2019","journal-title":"Horm Metab Res"},{"issue":"7","key":"10.1016\/j.eprac.2022.01.013_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/thy.2019.0522","article-title":"Experience with active surveillance of thyroid low-risk carcinoma in a developing country","volume":"30","author":"Sanabria","year":"2020","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.013_bib21","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/thy.2018.0263","article-title":"Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea","volume":"28","author":"Oh","year":"2018","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2022.01.013_bib22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2018.0462","article-title":"Active surveillance for T1bN0M0 papillary thyroid carcinoma","volume":"29","author":"Sakai","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2022.01.013_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00268-015-3349-1","article-title":"Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance","volume":"40","author":"Fukuoka","year":"2016","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.eprac.2022.01.013_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-20-1481","article-title":"Outcomes of active surveillance of EU-TIRADS 5 thyroid nodules","volume":"184","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2022.01.013_bib26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamasurg.2020.3290","article-title":"Changes in diagnosis of thyroid cancer among medicaid beneficiaries following Medicaid expansion","volume":"155","author":"Schuman","year":"2020","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2022.01.013_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.20892\/j.issn.2095-3941.2019.0470","article-title":"Active surveillance as a management strategy for papillary thyroid microcarcinoma","volume":"17","author":"Zhang","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.013_bib29","first-page":"1","article-title":"The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?","volume":"18","author":"Liu","year":"2021","journal-title":"Cancer Biol Med"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.surg.2017.03.028","article-title":"Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance","volume":"163","author":"Miyauchi","year":"2018","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/thy.2015.0393","article-title":"Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma hospital","volume":"26","author":"Ito","year":"2016","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2022.01.013_bib32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1001\/jamainternmed.2021.4804","article-title":"Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta-analysis of subclinical thyroid cancer rates at autopsy","volume":"181","author":"LeClair","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.eprac.2022.01.013_bib33","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ijc.33298","article-title":"Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases","volume":"148","author":"Liu","year":"2021","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.eprac.2022.01.013_bib34","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1089\/thy.2020.0845","article-title":"Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic workup strategies","volume":"31","author":"Lon\u010dar","year":"2021","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2022.01.013_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaoto.2018.1663","article-title":"Active surveillance in thyroid microcarcinoma in a Latin-American cohort","volume":"144","author":"Sanabria","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.013_bib36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1089\/thy.2019.0396","article-title":"Kinetic analysis of growth activity in enlarging papillary thyroid microcarcinomas","volume":"29","author":"Ito","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/thy.2015.0178","article-title":"A\u00a0clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.013_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17446651.2018.1449641","article-title":"A\u00a0clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management","volume":"13","author":"Tuttle","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.013_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eprac.2020.11.003","article-title":"National survey of endocrinologists and surgeons regarding active surveillance for low-risk papillary thyroid cancer","volume":"27","author":"Roman","year":"2021","journal-title":"Endocr Pract"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.013_bib40","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.ejso.2020.08.014","article-title":"Continuing controversy regarding individualized surgical decision-making for patients with 1-4 cm low-risk differentiated thyroid carcinoma: a systematic review","volume":"46","author":"Liu","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.eprac.2022.01.013_bib41","article-title":"Barriers to the use of active surveillance for thyroid cancer: results of a physician survey","author":"Hughes","year":"2020","journal-title":"Ann Surg"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:26Z","timestamp":1761516746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1530891X22000398"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.01.013","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Active Surveillance Management be Developed for Patients With Low-Risk Papillary Thyroid Microcarcinoma? A Preliminary Investigation in a Chinese Population","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}